Skip to main content
. 2017 May 9;2017:1569235. doi: 10.1155/2017/1569235

Figure 6.

Figure 6

Representative AP traces recorded from each group. (a) APs of each group treated for 3 weeks (n = 5). (b) APs of each group treated for 9 weeks (n = 5). (c) APD90 of each group after treatment with KN93 and 5 g/L WXKL for 3 weeks and 9 weeks (n = 5). ∗∗P < 0.01 versus the Sham group. #P < 0.05 and ##P < 0.01 versus the TAC group. P < 0.05 versus the TAC group after 3 weeks.